Paul A VanderLaan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Venues

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

University of Chicago Division of Biological Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Chicago Division of Biological Sciences Jul 01 2000 - Jun 30 2006

United States

PHD :: Pathology

Publications

Hollis Viray, Andrew J Piper-Vallillo, Page Widick, Emmeline Academia, Meghan Shea, Deepa Rangachari, Paul A VanderLaan, Susumu S Kobayashi, Daniel B Costa
A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice. Cancers 16 (6) (2024)
Cristiana M Pineda, Adnan Majid, Daniel B Costa, Paul A VanderLaan
Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions. Cancer cytopathology (2024)
Hollis Viray, Andrew J Piper-Vallillo, Page Widick, Emmeline Academia, Meghan Shea, Deepa Rangachari, Paul A VanderLaan, Susumu S Kobayashi, Daniel B Costa
A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice. Cancers 16 (6) (2024)
Yue Sun, Timothy D Weber, James G Fujimoto, Seymour Rosen, Paul A VanderLaan
Rapid examination of lung tissues by nonlinear microscopy. American journal of clinical pathology (2024)
Elizabeth A Hall, Pamela Hartzband, Paul A VanderLaan, Michiya Nishino
Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance. Cancer cytopathology (2023)
Elizabeth A Hall, Pamela Hartzband, Paul A VanderLaan, Michiya Nishino
Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance. Cancer cytopathology (2023)
Lois Janelle Starr, Mark E Lindsay, Deborah Perry, Gregory Gheewalla, Paul A VanderLaan, Adnan Majid, Charlie Strange, George-Claudiu Costea, Adrian Lungu, Angela E Lin
Review of the Pathologic Characteristics in Myhre Syndrome: Gain-of-Function Pathogenic Variants in SMAD4 cause a Multisystem Fibroproliferative Response. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society (2022)
Elena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, Eduardo Alcaraz-Mateos, Greta Alì, Syed Z Ali, Zubair W Baloch, Claudio Bellevicine, Massimo Bongiovanni, Pavlina Botsun, Dario Bruzzese, Lukas Bubendorf, Reinhard Büttner, Sule Canberk, Arrigo Capitanio, Chiara Casadio, Eugeniu Cazacu, Beatrix Cochand-Priollet, Alessandro D'Amuri, Katelynn Davis, Catarina Eloy, Marianne Engels, Guido Fadda, Gabriella Fontanini, Franco Fulciniti, Paul Hofman, Antonino Iaccarino, Antonio Ieni, Xiaoyin 'Sara' Jiang, Kennichi Kakudo, Izidor Kern, Ivana Kholova, Kathryn M Linton McDermott, Chinhua Liu, Anandi Lobo, María Dolores Lozano, Umberto Malapelle, Zahra Maleki, Pamela Michelow, Michael W Mikula, Jamal Musayev, Gonca Özgün, Meltem Oznur, Francisca Maria Peiró Marqués, David Poller, Michal Pyzlak, Betsy Robinson, Esther Diana Rossi, Sinchita Roy-Chowdhuri, Mauro Ajaj Saieg, Spasenija Savic Prince, Fernando C Schmitt, Francisco Javier Seguí Iváñez, Tajana Štoos-Veić, Oksana Sulaieva, Brenda J Sweeney, Giovanni Tuccari, Marie-Louise van Velthuysen, Paul A VanderLaan, Philippe Vielh, Patrizia Viola, Quirinus J M Voorham, Birgit Weynand, Pio Zeppa, William C Faquin Md PhD, Martha Bishop Pitman, Giancarlo Troncone
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study. Cancer cytopathology 130 (5) (2022)
Cynthia K Harris, Caitlin M Darrell, Paul A VanderLaan, Yael K Heher
Patient-facing communication for cytopathologists: A framework for disclosing diagnostic error. Cancer cytopathology (2022)
Paul A VanderLaan, Sinchita Roy-Chowdhuri
Current and future trends in non-small cell lung cancer biomarker testing: The American experience. Cancer cytopathology 128 (9) (2021)
Liza M Quintana, Mayra A Wells, Paul A VanderLaan, Vanda F Torous
A frameshift error affecting multiple cytology cell blocks: Lessons from a near-miss event. Cancer cytopathology (2021)
Allison M Onken, Paul A VanderLaan, James V Hennessey, Pamela Hartzband, Michiya Nishino
Combined molecular and histologic end points inform cancer risk estimates for thyroid nodules classified as atypia of undetermined significance. Cancer cytopathology 129 (12) (2021)
Andrew J Synn, Constance De Margerie-Mellon, Sun Young Jeong, Farbod N Rahaghi, Iny Jhun, George R Washko, Raúl San José Estépar, Alexander A Bankier, Murray A Mittleman, Paul A VanderLaan, Mary B Rice
Vascular remodeling of the small pulmonary arteries and measures of vascular pruning on computed tomography. Pulmonary circulation 11 (4) (2021)
Tapan K Biswas, Paul A VanderLaan, Xuchu Que, Ayelet Gonen, Paulette Krishack, Christoph J Binder, Joseph L Witztum, Godfrey S Getz, Catherine A Reardon
CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Ldlr-/- Mice. Antibodies (Basel, Switzerland) 9 (3) (2020)
Mayra A Medina, Allison M Onken, Constance de Margerie-Mellon, Benedikt H Heidinger, Yigu Chen, Alexander A Bankier, Paul A VanderLaan
Preoperative bronchial cytology for the assessment of tumor spread through air spaces in lung adenocarcinoma resection specimens. Cancer cytopathology 128 (4) (2020)
Yigu Chen, Paul A VanderLaan, Yael K Heher
Using the Model for Improvement and Plan-Do-Study-Act to effect SMART change and advance quality. Cancer cytopathology 129 (1) (2020)
Paul A VanderLaan, Deepa Rangachari, Daniel B Costa
The rapidly evolving landscape of biomarker testing in non-small cell lung cancer. Cancer cytopathology 129 (3) (2020)
Constance De Margerie-Mellon, Long H Ngo, Ritu R Gill, Antonio C Monteiro Filho, Benedikt H Heidinger, Allison Onken, Mayra A Medina, Paul A VanderLaan, Alexander A Bankier
The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT. Radiology 297 (1) (2020)
Yael K Heher, Yigu Chen, Paul A VanderLaan
Pre-analytic error: A significant patient safety risk. Cancer cytopathology (2019)
Lucian R Chirieac, Yin Pun Hung, Wai Chin Foo, Matthias D Hofer, Paul A VanderLaan, William G Richards, David J Sugarbaker, Raphael Bueno
Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma. Cancer 125 (23) (2019)
Paul A VanderLaan, Catherine A Reardon, Veneracion G Cabana, Chyung-Ru Wang, Godfrey S Getz
Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice. International journal of molecular sciences 20 (18) (2019)
Paul A VanderLaan
Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past? Cancer cytopathology 127 (5) (2019)
Magda Bahcall, Mark M Awad, Lynette M Sholl, Frederick H Wilson, Man Xu, Stephen Wang, Sangeetha Palakurthi, Jihyun Choi, Elena V Ivanova, Giulia C Leonardi, Bryan C Ulrich, Cloud P Paweletz, Paul T Kirschmeier, Masayuki Watanabe, Hideo Baba, Mizuki Nishino, Rebecca J Nagy, Richard B Lanman, Marzia Capelletti, Emily S Chambers, Amanda J Redig, Paul A VanderLaan, Daniel B Costa, Yu Imamura, Pasi A Jänne
Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (23) (2018)

Paul A VanderLaan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paul A VanderLaan